← All trials
NCT06886919
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 31, 2025
- Primary completion
- Sep 30, 2025
- Completion date
- May 30, 2026
- First posted
- Mar 20, 2025
- Last posted
- Mar 24, 2025
- Enrollment
- 6
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Beijing Immunochina Medical Science & Technology Co., Ltd.Lead sponsor
- Beijing Boren HospitalOfficial
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.